NFKB1 and glioblastoma: Although S276 phosphorylation is associated with increased NF-κB activity in multiple settings [33,34], this site is not routinely used as an indicator of NF-κB activation in GBM, possibly because of the discrepancy associated with the most commonly used anti-phospho-S276-p65 antibody [35].